Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease

Key Inclusion Criteria:

• Willing and able to understand and sign an approved informed consent form.

• Exhibit symptoms of dry eye at the Screening visit.

• Best Corrected Visual Acuity equal to or better than 20/80 Snellen in each eye atthe Screening visit.

• Willing to discontinue use of all artificial tear supplements and use only the studyproduct as directed starting at Visit 2/Day 1.

• Other protocol-defined inclusion criteria may apply.

Key Exclusion Criteria:

• Pregnant, breastfeeding, or planning to become pregnant during the study.

• Ocular abnormalities that could adversely affect the safety or efficacy outcome.

• Uncontrolled active systemic diseases.

• Use of systemic medications known to cause dry eye.

• Other protocol-defined exclusion criteria may apply.